The cell survival fraction, determined using a clonogenic assay, demonstrated that silencing DUSP6 reduced the radioresistance of RIG-I-overexpressing ESCC cells (Figure 7C, Supplementary Figure S4E). This evidence concerns the gene DUSP6 and esophageal squamous cell carcinoma.